— Know what they know.
Not Investment Advice

ETON NASDAQ

Eton Pharmaceuticals, Inc.
1W: +16.8% 1M: +48.2% 3M: +95.2% YTD: +115.2% 1Y: +78.6% 3Y: +872.2% 5Y: +324.2%
$32.59
-2.41 (-6.89%)
 
Weekly Expected Move ±11.7%
$23 $27 $30 $34 $37
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 69 · $892.7M mcap · 23M float · 1.84% daily turnover · Short 37% of daily vol

📊 Key Metrics

TTM
$87M
Revenue
+79.9% YoY
$-1M
Net Income
+67.8% YoY
$15M
Free Cash Flow
+179.5% YoY
60.7%
Gross Margin
9.9%
Op. Margin
6.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-5.8%
ROA-1.8%
ROIC17.0%

Valuation

P/E-602.9
P/B29.0
EV/EBITDA133.7

Leverage

Debt/Equity0.35
Current Ratio1.57
Interest Cov.1.0x

Quality Scores

Piotroski F6/9
Altman Z6.70
Beneish M-2.53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms